L. Wallentin
Department of Cardiology
University Hospital
Uppsala
Sweden
Name/email consistency: high
- Long-term management--the way forward?. Wallentin, L. Clin. Cardiol (2000)
- Implications of the FRISCII trial: initial medical stabilization followed by an early invasive approach is the preferred strategy in unstable coronary syndromes. Wallentin, L. Scand. Cardiovasc. J. (2000)
- Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease. Wallentin, L., Lagerqvist, B., Husted, S., Kontny, F., Ståhle, E., Swahn, E. Lancet (2000)
- Low molecular weight heparin in unstable coronary artery disease. Wallentin, L. Expert. Opin. Investig. Drugs (2000)
- Low-molecular-weight heparin as a bridge to timely revascularization in unstable coronary artery disease -- an update of the Fragmin during Instability in Coronary Artery Disease II Trial. Wallentin, L. Haemostasis (2000)